A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

February 19, 2008

Starting Treatment With Higher CD4s Cuts Death Rate

People who start antiretroviral treatment with CD4 counts above 350 have the lowest risk of disease progression and death compared with people who start at CD4 counts below 350, say the authors of a study published in the February 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS) and reported by AIDSmap. The study lends further support to a trend, marked by recent changes to U.S. HIV treatment guidelines, suggesting that antiretroviral therapy should be started earlier than had been previously recommended.

A research team headed by Ángeles Jaén, MD, PhD, from the Centre d’Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya in Badalona, Spain, reviewed the medical records from a large group of people living with HIV, called the PICSCIS cohort, being cared for at 10 hospitals throughout Spain. Nearly 7,000 people living with HIV were followed between 1998 and December 2004.

Dr. Jaén’s team closely evaluated records for 2,035 people who had started a three-drug combination antiretroviral regimen and who had their CD4 counts measured within six months before starting treatment. The patients were then split into three groups: those who waited to start antiretroviral therapy until their CD4 count had dropped below 200; those who started treatment at a CD4 count between 200 and 350; and those who started treatment with a CD4 count greater than 350.

A total of 148 patients progressed to AIDS or died over an average of roughly three years of follow-up. Using a relatively simple comparative analysis, the authors found that a number of factors were associated with an increased risk of disease progression. These included starting treatment with a CD4 count of less than 200, having a high viral load, being of older age, being an injection-drug user and being coinfected with hepatitis C (HCV).

After controlling for a number of factors, Jaén’s team found that people who started treatment with a CD4 count between 200 and 350 had a lower risk of disease progression than people who waited to start treatment until their CD4 count dropped below 200. Similar results from other studies recently inspired the United States and Europe to revise their HIV treatment guidelines, which now recommend that antiretroviral treatment be started in people with CD4 counts below 350. Jaén’s team asserts that the results of their study support those guidelines’ changes.

An additional finding, that the risk of disease progression in people who started treatment at CD4 counts above 350 was lower than in people who started treatment at CD4 counts between 200 and 350, lends credibility to the belief that even moderate levels of immune suppression may be harmful, and raises the question of whether starting treatment even earlier may be warranted.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 4 (of 4 total)    

JADE, , 2008-03-16 16:27:49
I believe aids is only a health situation who must be handle by the person as to be a personal daily basis. aim a hiv person for 18 yrs I start Med on 2008 I feel great , better at never SO be positive be your self

MICHAEL GIANNINI, Charlottesville, 2008-03-08 21:02:35
been on Atripla since dec 06 viral load gone from 255,000 to les then 50 C4 count from 327 to 773 main concern med cost so much , not sure how much longer I can afford it

don, seattle, 2008-02-24 00:30:45
I started meds when i was bouncing around between 350-400 for a year or so, but I was so exhausted and depressed with a lack of energy and GI tract issues I felt the need to start. Within a month it was amazing the difference. Within a year my counts were over 600 and undectable, with no side effects. I wished I had started sooner. They say HIV attacks in the gut first, and in my case I certainly felt my system was being damaged long before "350". Who came up with that number anyway?

phillip, rochester, 2008-02-23 03:53:39
what about my situation is this ... im first year poz and viral load of 98 and cd4 counts of 1050..so if i wer to start to progress quickly should i start meds sooner like 500 i get checked quarterly ? and should i start now while its so low a viral load?

comments 1 - 4 (of 4 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    jakeinps
    Desert Cities
    California


    RealCat2005
    Bergenfield
    New Jersey


    audipoz
    Seattle/Eastern Washington
    Washington


    BLatinoGuy
    Fayetteville
    North Carolina
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.